CCL4 and osteosarcoma: Here, our use of MVC to block the function of the CCL4/CCR5 axis successfully inhibited integrin αvβ3 expression as well as the migration of osteosarcoma cells, indicating that MVC has therapeutic efficacy in osteosarcoma metastasis.